Dose-response curves for four neuromuscular blockers using continuous i.v. infusion

Area of Science:

• Anesthesiology
• Pharmacology
• Clinical Research

Background:

• Neuromuscular blocking drugs are essential in modern anesthesia.
• Understanding their dose-response relationships is critical for safe and effective patient care.

Purpose of the Study:

• To construct cumulative dose-response curves for tubocurarine, pancuronium, gallamine, and alcuronium in humans.
• To determine the ED50 for each neuromuscular blocking agent under specific anesthetic conditions.

Main Methods:

• Fifty-six adult patients received one of four neuromuscular blocking drugs via constant-rate infusion during barbiturate-narcotic-nitrous oxide anesthesia.
• Cumulative dose-response curves were generated using mechanical twitch response measurements.
• Electromyogram recordings were also utilized for alcuronium.

Main Results:

• The ED50 values (mg kg-1) were: tubocurarine 0.236, pancuronium 0.048, gallamine 1.3, and alcuronium 0.161.
• Pancuronium and alcuronium demonstrated significantly steeper dose-response curve slopes compared to tubocurarine and gallamine.
• Alcuronium's ED50 based on electromyogram was 0.135 mg kg-1, indicating greater depression than the mechanical twitch response.

Conclusions:

• This study provides key ED50 data for commonly used neuromuscular blocking agents.
• The steeper slopes for pancuronium and alcuronium suggest a more predictable dose-response relationship.
• Electromyogram may offer a more sensitive measure of neuromuscular blockade than mechanical twitch response for certain agents.